Laboratory Diagnosis of HEV Infection

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2023 May 24

PMID 37223868

Authors

Chenyan Zhao

Youchun Wang

Affiliations

Soon will be listed here.

Abstract

Serological and nucleic acid tests for detecting hepatitis E virus (HEV) have been developed for both epidemiologic and diagnostic purposes. The laboratory diagnosis of HEV infection depends on the detection of HEV antigen or HEV RNA in the blood, stool, and other body fluids, and serum antibodies against HEV (immunoglobulin [Ig]A, IgM, and IgG). Anti-HEV IgM antibodies and low avidity IgG can be detected during the acute phase of the illness and can last approximately 12 months, representing primary infection, whereas anti-HEV IgG antibodies can last more than several years, representing remote exposure. Thus, the diagnosis of acute infection is based on the presence of anti-HEV IgM, low avidity IgG, HEV antigen, and HEV RNA, while epidemiological investigations are mainly based on anti-HEV IgG. Although significant progress has been made in developing and optimizing different formats of HEV assays, improving their sensitivity and specificity, there are many shortcomings and challenges in inter-assay concordance, validation, and standardization. This article reviews the current knowledge on the diagnosis of HEV infection, including the most common available laboratory diagnostic techniques.

References

Dalton H, Bendall R, Keane F, Tedder R, Ijaz S . Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009; 361(10):1025-7. DOI: 10.1056/NEJMc0903778. View

Kamar N, Selves J, Mansuy J, Ouezzani L, Peron J, Guitard J . Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008; 358(8):811-7. DOI: 10.1056/NEJMoa0706992. View

Khuroo M . Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res. 2011; 161(1):3-14. DOI: 10.1016/j.virusres.2011.02.007. View

Miyamura T . Hepatitis E virus infection in developed countries. Virus Res. 2011; 161(1):40-6. DOI: 10.1016/j.virusres.2011.03.006. View

Zhu F, Zhang J, Zhang X, Zhou C, Wang Z, Huang S . Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010; 376(9744):895-902. DOI: 10.1016/S0140-6736(10)61030-6. View

Bradley D, Krawczynski K, Humphrey C, McCaustland K . Biochemically silent posttransfusion non-A, non-B hepatitis interferes with superinfection by hepatitis A virus. Intervirology. 1987; 27(2):86-90. DOI: 10.1159/000149724. View

Krawczynski K, Bradley D . Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis. 1989; 159(6):1042-9. DOI: 10.1093/infdis/159.6.1042. View

Khuroo M, Rustgi V, Dawson G, MUSHAHWAR I, Yattoo G, Kamili S . Spectrum of hepatitis E virus infection in India. J Med Virol. 1994; 43(3):281-6. DOI: 10.1002/jmv.1890430316. View

Krawczynski K, Meng X, Rybczynska J . Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res. 2011; 161(1):78-83. DOI: 10.1016/j.virusres.2011.03.007. View

10.

Geng Y, Zhao C, Huang W, Harrison T, Zhang H, Geng K . Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol. 2015; 64(1):37-43. DOI: 10.1016/j.jhep.2015.08.034. View

11.

Mushahwar I . Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol. 2008; 80(4):646-58. DOI: 10.1002/jmv.21116. View

12.

Favorov M, Fields H, Purdy M, Yashina T, Aleksandrov A, Alter M . Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol. 1992; 36(4):246-50. DOI: 10.1002/jmv.1890360403. View

13.

Huang S, Zhang X, Jiang H, Yan Q, Ai X, Wang Y . Profile of acute infectious markers in sporadic hepatitis E. PLoS One. 2010; 5(10):e13560. PMC: 2958841. DOI: 10.1371/journal.pone.0013560. View

14.

Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K . Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005; 43(1):49-56. PMC: 540162. DOI: 10.1128/JCM.43.1.49-56.2005. View

15.

Dawson G, Chau K, Cabal C, Yarbough P, Reyes G, MUSHAHWAR I . Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods. 1992; 38(1):175-86. DOI: 10.1016/0166-0934(92)90180-l. View

16.

Khuroo M, Kamili S, Dar M, Moecklii R, Jameel S . Hepatitis E and long-term antibody status. Lancet. 1993; 341(8856):1355. View

17.

Chau K, Dawson G, Bile K, Magnius L, Sjogren M, MUSHAHWAR I . Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J Med Virol. 1993; 40(4):334-8. DOI: 10.1002/jmv.1890400414. View

18.

Herremans M, Bakker J, Duizer E, Vennema H, Koopmans M . Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol. 2007; 14(5):562-8. PMC: 1865643. DOI: 10.1128/CVI.00231-06. View

19.

Tokita H, Harada H, Gotanda Y, Takahashi M, Nishizawa T, Okamoto H . Molecular and serological characterization of sporadic acute hepatitis E in a Japanese patient infected with a genotype III hepatitis E virus in 1993. J Gen Virol. 2003; 84(Pt 2):421-427. DOI: 10.1099/vir.0.18802-0. View

20.

Gerolami R, Moal V, Picard C, Colson P . Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol. 2009; 50(3):622-4. DOI: 10.1016/j.jhep.2008.12.008. View